These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37082491)

  • 21. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease.
    Osman IM; Godden DJ; Friend JA; Legge JS; Douglas JG
    Thorax; 1997 Jan; 52(1):67-71. PubMed ID: 9039248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of post-tuberculosis lung disease on health-related quality of life in patients from two tertiary hospitals in Lagos, Nigeria.
    Ozoh OB; Ojo OO; Dania MG; Dede SK; Adegboyega OA; Irurhe NK; Olowoyeye M; Adeyeye OO
    Afr J Thorac Crit Care Med; 2021; 27(2):. PubMed ID: 34430871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exercise training for bronchiectasis.
    Lee AL; Gordon CS; Osadnik CR
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013110. PubMed ID: 33822364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Kew KM; Mavergames C; Walters JA
    Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
    Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.
    Kreuter M; Swigris J; Pittrow D; Geier S; Klotsche J; Prasse A; Wirtz H; Koschel D; Andreas S; Claussen M; Grohé C; Wilkens H; Hagmeyer L; Skowasch D; Meyer JF; Kirschner J; Gläser S; Kahn N; Welte T; Neurohr C; Schwaiblmair M; Held M; Bahmer T; Oqueka T; Frankenberger M; Behr J
    Respir Res; 2019 Mar; 20(1):59. PubMed ID: 30876420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Post-Treatment Health-Related Quality of Life among Patients with Pulmonary Tuberculosis in Ilorin, Nigeria.
    Ojuawo OB; Desalu OO; Fawibe AE; Aladesanmi AO; Ojuawo AB; Salami AK
    West Afr J Med; 2021 Jan; 38(1):28-34. PubMed ID: 33463704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study.
    Meghji J; Lesosky M; Joekes E; Banda P; Rylance J; Gordon S; Jacob J; Zonderland H; MacPherson P; Corbett EL; Mortimer K; Squire SB
    Thorax; 2020 Mar; 75(3):269-278. PubMed ID: 32102951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Etiology and outcome of moderate-to-massive hemoptysis: Experience from a tertiary care center of North India.
    Bhalla A; Pannu AK; Suri V
    Int J Mycobacteriol; 2017; 6(3):307-310. PubMed ID: 28776532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cause of massive hemoptysis in critical patients and the effect of bronchial artery embolization].
    Xi Y; Liu D; Yang C; Wu X; Nong L; He W; Liu X; Li Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):671-676. PubMed ID: 30045796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of diabetes mellitus amongst hospitalized tuberculosis patients at an Indian tertiary care center: A descriptive analysis.
    Pande T; Huddart S; Xavier W; Kulavalli S; Chen T; Pai M; Saravu K
    PLoS One; 2018; 13(7):e0200838. PubMed ID: 30021016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of coinfection with human immunodeficiency virus and pulmonary tuberculosis on the success of bronchial artery embolisation.
    Govind M; Maharajh J
    Br J Radiol; 2013 Jan; 86(1021):20120256. PubMed ID: 23255543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchial Angioembolization for Management of Hemoptysis Due to Pulmonary Tuberculosis.
    Seyyedi SR; Tabarsi P; Sadr M; Aloosh O; Keshmiri MS; Abedini A; Marjani M; Moniri A; Chitsazan M; Azimi M; Sharif-Kashani B
    Tanaffos; 2021 Feb; 20(2):134-139. PubMed ID: 34976084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary rehabilitation for interstitial lung disease.
    Dowman L; Hill CJ; May A; Holland AE
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD006322. PubMed ID: 34559419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of two quality-of-life instruments for patients with chronic obstructive pulmonary disease.
    Alemayehu B; Aubert RE; Feifer RA; Paul LD
    Value Health; 2002; 5(5):437-42. PubMed ID: 12201861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of INF-γ as an immunological healing marker based on anti-tubercular treatment among diabetic and non-diabetic pulmonary tuberculosis patients.
    Yadav BK; Shah AK; Karunanand B; Sudan DS; Sharma M
    Horm Mol Biol Clin Investig; 2023 Mar; 44(1):33-37. PubMed ID: 36148507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Airway clearance techniques for bronchiectasis.
    Lee AL; Burge A; Holland AE
    Cochrane Database Syst Rev; 2013 May; (5):CD008351. PubMed ID: 23728674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).
    Janjua S; Carter D; Threapleton CJ; Prigmore S; Disler RT
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013196. PubMed ID: 34693988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Spectrum and Medical Comorbidities in Tuberculosis: A Hospital-Based Study in Northeast India.
    Bhattacharya P; Talukdar K; Barman B; Jamil M; Phukan P; Mobing H; War G; Nonglait PL; Murti S; Prithviraj K; Sangma B
    Cureus; 2020 Sep; 12(9):e10580. PubMed ID: 33110716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of bronchial artery embolization for life-threatening hemoptysis due to tuberculosis and post-tuberculosis sequelae.
    Anuradha C; Shyamkumar NK; Vinu M; Babu NR; Christopher DJ
    Diagn Interv Radiol; 2012; 18(1):96-101. PubMed ID: 21678246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.